ArticleCancer drug resistance (Alhambra, Calif.)2021

Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.

Robert Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.